DBVTF — DBV Technologies S.A.

—
Nasdaq · Health Care · Biotechnology · CIK 1613780 · France
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
2026-10-28

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -64,800,000 -64,500,000 215,400,000 165,700,000 66,800,000
Jun 2026 0 — -50,600,000 -50,400,000 223,200,000 174,900,000 62,800,000
Mar 2026 0 — -47,900,000 -47,600,000 266,400,000 229,200,000 58,500,000
Dec 2025 0 — -45,048,000 -44,829,000 233,718,000 194,167,000 64,948,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-188,476,000
Investing CF
$-6,914,000
Financing CF
$296,060,000
CapEx
$-3,379,000
Dividends Paid
—
Buybacks
$-200,000
EPS Diluted TTM
$-0.68
As of
2026-11-01

Balance + Analyst (yfinance extras)

Retained Earnings
$-334,800,000
Inventory
—
Receivables
$17,500,000
ST Investments
—
EBIT TTM
$-208,348,000
Pretax Income TTM
$-206,255,000
Interest Exp TTM
—
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$3,762,000
EBITDA
$-205,476,000
Free Cash Flow
$-124,780,752
Enterprise Value
$464,289,824
Total Cash
$165,700,000
Total Debt
$7,500,000
Shares Out
314,203,537
Trailing EPS
$-0.60
Book Value
$0.47
ROE
-205.8%
ROA
-79.9%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -147,054,000 -146,947,000 233,718,000 64,948,000 168,770,000 -121,181,000
Dec 2024 0 -116,590,000 -113,918,000 65,658,000 38,271,000 27,388,000 -104,474,000
Dec 2023 0 -76,433,000 -72,726,000 182,986,000 42,799,000 140,186,000 -79,653,000
Dec 2022 0 -96,631,000 -96,274,000 246,518,000 52,065,000 194,454,000 -55,666,000

TTM Snapshot

Revenues TTM
$5,018,000
NetIncome TTM
$-175,993,000
OpCashFlow TTM
—
Assets (Latest)
$223,200,000
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
AMGN AMGEN INC $247.70B $457.93 —
GILD GILEAD SCIENCES, INC. $211.18B $170.26 —
MRNA Moderna, Inc. $82.56B $206.80 —
ARGX ARGENX SE $58.92B $947.52 —
BIIB BIOGEN INC. $37.07B $250.79 —

News headlines (Yahoo Finance, 1h cache)

DBV Technologies: 3 Key Takeaways for Long-Term Investors
2026-11-18 20:05 · Yahoo
European Equities Traded in the US as American Depositary Receipts Kick Off Week Lower in Monday Trading
2026-11-16 16:21 · Yahoo
European Equities Traded in the US as American Depositary Receipts Rise Marginally in Friday Trading
2026-11-13 16:17 · Yahoo
DBV Technologies Highlights New Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years
2026-11-12 15:00 · Yahoo
European Equities Traded in the US as ADRs Tick Higher in Wednesday Trading
2026-11-11 16:12 · Yahoo
DBV Technologies Prepares Peanut Patch Launch as FDA Filing Decision Nears
2026-11-09 15:14 · Yahoo
European Equities Traded in the US as American Depositary Receipts Advance Sharply in Wednesday Trading
2026-11-04 16:13 · Yahoo
European Equities Traded in the US as American Depositary Receipts Decline Slightly in Tuesday Trading
2026-11-03 16:23 · Yahoo
DBV Technologies to Participate in Upcoming November Investor Conferences
2026-11-02 21:30 · Yahoo
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
2026-11-02 16:16 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.